Ribogenix is a RNA genomics company dedicated to the identification of human sequence variants that regulate gene expression at the RNA level. Its mission is to apply this knowledge to the diagnosis and treatment of human disease.
The platform technology is the ability to discern RNA:RNA interactions that govern cellular function. This technology affords the opportunity to synergize with next generation human genome sequencing and precociously design novel RNA therapeutics
|
|
|